Competition authorities in the UK gave green light in Astra Zeneca’s $39bn takeover deal of US giant Alexion Pharmaceuticals delivering the British pharma a lucrative portfolio of immunology and a towering presence in rare diseases. Astra Zeneca on Wednesday announced the completion of its Alexion acquisition, a week after securing a pivotal nod from UK’s…
The first new treatment of Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States clearing the way for its use in the UK. Aducanumab targets amyloid, a protein that forms abnormal; crumps in the brains of people with Alzheimer’s that can damage cells and trigger dementia, communication issues, memory…
Heavy Light is the story of a mental breakdown, a journey through mania, psychosis, and treatment in a psychiatric hospital, and onwards to release, recovery and healing. Heavy Light deal with a lifetime of ups and downs, from hypomania in the Alps to a complete breakdown and a locked ward in Wakefield, explaining how…
Three generations of the Sackler dynasty and their roles in the stories of the opioid Valium, and Opioid OxyContin, revealing misery, greed and pliant regulators and the abuse of philanthropy. Patrick Radden Keefe, a New Yorker writer and prize-winning, bestselling author of Say Nothing, reveals the inside story. In 1980s, a small UK drugs company…
A weekly injection of semaglutide, along with a special diet and fitness would suppress appetite and has led some people to lose more than a fifth of their body weight, according to a major international trial. The study conducted on 2, 000 people revealed an average 15kg weight loss during the 15-month trial. Scientists said…
Respected financial journalist Alex Brummer and Brexit supporter was offering an argument for optimism in his must read book The Great British Reboot, and offers a manifesto for how to re-engineer the UK economy. Brummer’s prescriptions align with Prime Minister Boris Johnson’s political prospectus, despite the gap between strategy and implementation remains wide apart. His analysis of…
Stock Markets have rocketed on the hopes of potential breakthrough in the search for a vaccine against Covid-19. Drugs firm Pfizer’s own shares climbed 9 per cent after it had that preliminary analysis indicated that its coronavirus vaccine was 90 per cent effective. The owner of British Airways, International Airlines Group (IAG) rose 40…
China is now the newest country in the world following the footsteps of Russia to register its novel vaccine for Covid-19 produced by CanSino biopharmaceutical firm. Chinese authorities granted the patent after studies proved that the vaccine prototype concurred with creative and intellectual property bases set by Beijing officials. The Chinese vaccine titled Ad5-nCOV was…
The UK government has signed a deal for a further 90 million coronavirus vaccine with the Belgian Pharmaceutical company Janssen and the US biotech company Novavax. This brings the tally of UK orders for six experimental vaccines to 340 million doses including 100 million doses of Adenovirus vaccines by Oxford University/ AstraZeneca, 30…
Researches behind a global study into Hydroxychloroquine led by Oxford University have against dismissing the drug prematurely, saying it could still save lives. The study, known as Copcov, aims to enroll 40, 000 healthcare workers from across the world to determine whether the drug is effective at fighting Covid-19. Dr. Will Schilling the trail’s lead…